| Ytd | -44.98% | |
| 1y | -66.69% |
| Open | 0.49 | Prev Close | 0.49 | Low | 0.49 | High | 0.54 | Mkt Cap | 4.09M |
| Vol | 52.86K | Avg Vol | 30.95K | EPS | -0.42 | P/E | N/A | Forward P/E | -0.47 |
| Beta | 2.05 | Short Ratio | 0.22 | Inst. Own | 5.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 0.58 | 200-d Avg | 0.79 | 1yr Est | 10.00 |
MBIO News
VANCOUVER, British Columbia, June 09, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include pa
This news release has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid
Vancouver, British Columbia – April 1, 2026 – TheNewswire - MindBio Therapeutics Corp. (CSE: MBIO);
Vancouver, British Columbia – TheNewswire - March 19, 2026 – MindBio Therapeutics Corp. (CSE: MBI
Mustang Bio (NASDAQ: MBIO - Get Free Report) and AstraZeneca (NASDAQ: AZN - Get Free Report) are bot
Vancouver, British Columbia - TheNewswire - February 18, 2026 – MindBio Therapeutics Corp. (CSE:
Vancouver, British Columbia – TheNewswire - February 18, 2026 – MindBio Therapeutics Corp. (CSE: MBI
Toronto, Ontario--(Newsfile Corp. - Le 4 novembre/November 2025) - MindBio Therapeutics Corp. has an
TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”) (TS
Mustang Bio surges 180% after its brain cancer therapy, MB-101, earns FDA Orphan Drug status for two
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 400 poin
Shares of Mustang Bio (NASDAQ: MBIO) surged on Monday as investors responded to a significant approv
In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patie
Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply in today's pre-market trading
WALTHAM, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (N
WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Na
WORCESTER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (
WORCESTER, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (
WORCESTER, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (